Paydirt
DA
Insider

Daniel Joseph Apel

Chief Financial Officer

Daniel Joseph Apel (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $853K of ARWR (11,938 sh across 2 lots, as filed), executed Apr 22.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$853K
shares × price, as filed
Last traded
Apr 22
Filed Apr 24

Median ADV $181.7M across their filed names

Open performance→
Volume by month
$853K$426K$0Oct 2024Apr 2025Oct 2025Apr 2026Apr 2026 · sells $853K
Buys $0 Sells $853K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
ARWR Arrowhead Pharmaceuticals, Inc. ARWR · 0 buys · 1 sell 1 filing
Recent filings
ARWRSALE Arrowhead Pharmaceuticals, Inc. View filing → $853K
11,938 sh across 2 lots
Exec Apr 22
Filed Apr 24 · 5:30 PM ET